Invasive Fungal Infections

This means a fungus is growing deep inside your body, like in your tissues or blood. It's a serious infection that needs medical treatment.

Condition

What people with Invasive Fungal Infections report

Every report comes from a Lived member, sent anonymously.

Have you tried Vfend (Voriconazole) for Invasive Fungal Infections?

NameHow it went

About Invasive Fungal Infections

What It Is

An invasive fungal infection is a fungal infection that has moved beyond the skin, nails or the lining of the mouth or genitals and into the bloodstream, the lungs or other internal organs. This sets it apart from familiar problems such as athlete's foot or a vaginal yeast infection, which stay on the surface. Invasive infections are uncommon, but they are serious and can be life-threatening, partly because they are often hard to recognize early and hard to clear. The term covers several different diseases. Invasive candidiasis is caused by Candida, a yeast that normally lives on the body; when it reaches the blood it is called candidemia. Invasive aspergillosis is caused by Aspergillus, a mold found almost everywhere indoors and out, and usually starts in the lungs. Mucormycosis is a rarer mold infection that typically attacks the sinuses or lungs and can spread quickly. Some fungi found in soil in particular regions of the United States, such as those causing Valley fever, histoplasmosis and blastomycosis, usually cause a mild lung illness but occasionally spread through the body.

Causes & Risk Factors

Fungi are part of everyday life. People breathe in mold spores daily, and Candida lives harmlessly on the skin and in the gut. A healthy immune system normally keeps them in check, so invasive infection usually happens when those defenses are weakened or bypassed. The people at highest risk include those receiving chemotherapy, especially when it causes a prolonged drop in neutrophils (the white blood cells that fight fungi); people who have had a stem cell or organ transplant; and people taking high doses of steroids or other medicines that suppress the immune system. Invasive candidiasis is closely tied to hospital care: a central line (a catheter placed in a large vein), recent surgery, intensive care and injection drug use all give yeast a route into the blood. Poorly controlled diabetes raises the risk of mucormycosis. The regional soil fungi are different: they can infect healthy people who breathe in contaminated dust, although illness is more likely to become severe when immunity is weak. These infections are generally not caught from other people. Risk reflects a person's health and medical treatment, not anything they did wrong.

How It's Diagnosed

Diagnosis is often difficult because early symptoms, such as fever, chills, cough or chest pain, look like many other infections. Clinicians combine several kinds of evidence rather than relying on one test. Blood cultures, in which a sample of blood is incubated to see whether yeast grows, are the main test for candidemia, but they miss roughly half of invasive Candida infections. Blood tests that detect pieces of fungal cell walls, called beta-D-glucan and galactomannan, can add evidence, although they can be falsely positive or negative. When a mold infection of the lungs is suspected, a CT (computed tomography) scan of the chest, a detailed X-ray image, can show patterns typical of fungal disease, and bronchoscopy (passing a thin tube into the airways to collect fluid) can provide samples for testing. The most definite diagnosis comes from finding the fungus in a tissue sample (biopsy) or growing it from a normally sterile site, but that is not always safe or possible in a very ill person. Doctors often start treatment on strong suspicion while confirming the diagnosis. People with candidemia usually also have a dilated eye exam, because Candida in the blood can spread to the eye.

Treatment Options

Treatment depends on which fungus is responsible, where it has spread and how sick the person is. Antifungal medicines are the core of treatment and are usually started through a vein (IV) in the hospital, sometimes switching to tablets once the person is stable and the fungus is known to be susceptible. For candidemia, an echinocandin (an IV antifungal family that includes caspofungin and micafungin) is usually the first choice, with fluconazole (Diflucan) an option in selected people. For invasive aspergillosis, voriconazole (Vfend) is the usual first treatment, with isavuconazole or a lipid form of amphotericin B as alternatives. Mucormycosis is treated with amphotericin B and usually needs prompt surgery to remove dead and infected tissue. Several of these medicines interact with many other drugs, and blood levels of some, such as voriconazole, are checked to make sure the dose is effective and safe. Treating the underlying situation matters as much as the medicine. That can mean removing an infected central line, bringing blood sugar under control, or reducing immune-suppressing medicines when it is safe to do so. For people at very high risk, such as some transplant recipients and people with prolonged low white cell counts after chemotherapy, doctors may give antifungal medicine in advance to prevent infection. Growing resistance to antifungals, including in Aspergillus and the hospital yeast Candida auris, can narrow the choices and is one reason identifying the exact fungus is important.

What to Expect

Invasive fungal infections usually mean a hospital stay and a long course of treatment. Candidemia is generally treated for at least two weeks after the blood is clear of yeast, with repeat blood cultures to confirm clearance. Invasive aspergillosis is typically treated for at least 6 to 12 weeks, and often longer while the immune system remains weak, so treatment frequently continues at home with tablets. The outlook varies widely. It depends on the type of fungus, how far it has spread, how quickly treatment began and, above all, whether the immune system recovers. These infections still carry a substantial risk of death, and mucormycosis has a particularly high death rate even with surgery. Many people do recover, but recovery can be slow and may be shaped as much by the illness that made them vulnerable as by the infection itself. Follow-up usually includes repeat scans or blood tests to see whether the infection is shrinking, monitoring of liver function and medicine levels, and careful review of any new prescriptions for interactions. People who remain at risk, for example during further chemotherapy or after a transplant, may continue preventive antifungal medicine.

When to Seek Help

If you have a weakened immune system from chemotherapy, a transplant or immune-suppressing medicines, follow your care team's instructions for fever exactly and call them right away for a new fever or chills. Contact them promptly the same day for a new cough, chest pain, shortness of breath or coughing up blood. Seek emergency care immediately for swelling around the eye or face, a black or dark area in the nose or on the face, or new confusion, particularly with diabetes or weakened immunity, because these can signal mucormycosis, which needs urgent surgery and treatment.

Questions to Ask Your Doctor

  1. 1.Which fungus is causing this infection, and how sure are we of the diagnosis?
  2. 2.Why was this antifungal chosen, how long will treatment last, and how will we know it is working?
  3. 3.Do any of my other medicines interact with my antifungal, and will my blood levels be checked?
  4. 4.What can be done about the underlying reason I was vulnerable, such as my immune suppression, a central line or blood sugar control?
  5. 5.Will I need preventive antifungal medicine during future treatment, and what signs should make me call you?

Last reviewed • Oct 2026

Educational content, not medical advice.